Your session is about to expire
← Back to Search
Behavioural Intervention
Weight Loss Interventions for Physical Disabilities
N/A
Waitlist Available
Led By Joseph Donnelly, EdD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Unable to participate in light-to-moderate intensity PA, e.g., seated aerobics, resistance exercise, or physically unable to use the iPad.
Unwilling to be randomized.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6, 12, and 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two weight loss programs for overweight or obese adults with mobility-related disabilities. One program involves home visits, and the other uses video conferencing for group sessions. Both programs provide dietary advice, physical activity recommendations, and self-monitoring tools to help participants lose weight.
Who is the study for?
Adults over 18 with a BMI above 25 and mobility-related disabilities requiring wheelchair use or similar assistance, who have stable weight and internet at home. Excluded are those on special diets, recent structured weight loss programs, significant health risks, cognitive impairments, or psychiatric conditions.
What is being tested?
The study compares two weight loss interventions for adults with physical disabilities: individual home visits versus group sessions via video conferencing. It measures success by weight loss over six months and maintenance up to eighteen months.
What are the potential side effects?
Since the trial involves dieting and exercise modifications rather than medication, side effects may include typical dieting experiences such as hunger or fatigue and exercise-related issues like muscle soreness.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot do light exercises or use an iPad.
Select...
I am not open to being randomly assigned to a treatment group.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6, 12, and 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 12, and 18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Weight Change in kg From Baseline to 6-months
Secondary study objectives
Blood Pressure
Change in Quality of Life
Cost of Intervention
+2 moreOther study objectives
Barriers to Exercise
Behavioral Session Attendance
Compliance With Physical Activity Recommendations
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Individual In-PersonExperimental Treatment2 Interventions
Group II: Group RemoteExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Individual In-Person
2020
N/A
~130
enhanced Stop Light Diet
2020
N/A
~130
Group Remote
2020
N/A
~130
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral modification and support interventions, such as Individual Home Visit (IH) and Group Remote Intervention via Video Conferencing (GR), primarily work by promoting lifestyle changes that enhance physical activity and dietary habits. These interventions often include personalized coaching, goal setting, and regular monitoring to encourage adherence to healthy behaviors.
For patients with physical disabilities, these mechanisms are crucial as they help in managing weight, improving mobility, and reducing cardiovascular risk factors, thereby enhancing overall quality of life and functional independence.
Interventions to Improve Movement and Functional Outcomes in Adult Stroke Rehabilitation: Review and Evidence Summary.Mechanism-specific rehabilitation management of complex regional pain syndrome: Proposed recommendations from evidence synthesis.Effect of affordable technology on physical activity levels and mobility outcomes in rehabilitation: a protocol for the Activity and MObility UsiNg Technology (AMOUNT) rehabilitation trial.
Interventions to Improve Movement and Functional Outcomes in Adult Stroke Rehabilitation: Review and Evidence Summary.Mechanism-specific rehabilitation management of complex regional pain syndrome: Proposed recommendations from evidence synthesis.Effect of affordable technology on physical activity levels and mobility outcomes in rehabilitation: a protocol for the Activity and MObility UsiNg Technology (AMOUNT) rehabilitation trial.
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
512 Previous Clinical Trials
176,604 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,455 Previous Clinical Trials
4,334,979 Total Patients Enrolled
Joseph Donnelly, EdDPrincipal InvestigatorUniversity of Kansas Medical Center
2 Previous Clinical Trials
474 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been part of a weight loss or exercise program in the last 6 months.I use a wheelchair or can't walk 0.25 miles due to a long-term disability.I am 18 years old or older.I am not currently using antipsychotics, and I don't have untreated depression or other psychiatric illnesses that would stop me from participating in weight management.I cannot do light exercises or use an iPad.You have a pattern of excessive eating or other eating disorders.My doctor has identified a serious health risk like cancer or heart issues.I am not open to being randomly assigned to a treatment group.
Research Study Groups:
This trial has the following groups:- Group 1: Individual In-Person
- Group 2: Group Remote
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.